Blue chip shares are often the cornerstone of long-term portfolios. They offer stability, strong market positions, and the ability to grow earnings through multiple economic cycles.
And with recent volatility pulling several high-quality names down meaningfully, analysts see buying opportunities emerging across the ASX 200.
For example, here are three ASX 200 blue chip shares that brokers have flagged as top buys right now. They are as follows:
Cochlear Ltd (ASX: COH)
Cochlear could be an ASX 200 blue chip share to buy. It is a leader in implantable hearing devices globally. Demand for its products continues to rise as ageing populations grow and access to hearing treatments expands worldwide.
The company's ongoing investment in research and new product development has helped it maintain its dominant market share and support steady revenue growth. And with a strong balance sheet, rising volumes, and a history of delivering consistent earnings and dividends, Cochlear continues to stand out as a reliable long-term compounder.
UBS is a fan of the company and has a buy rating and a $350.00 price target on the stock. This implies around 30% upside from current levels.
CSL Ltd (ASX: CSL)
Global biotech heavyweight CSL has come under pressure in recent months, with investor sentiment dampened by the planned Seqirus spin-off, regulatory uncertainty, and a slower-than-hoped recovery in plasma margins. But despite recent share price weakness, CSL's long-term fundamentals remain strong.
CSL continues to invest in expanding its plasma collection network, developing new therapies, and strengthening its manufacturing footprint in the United States. Demand for its core plasma-derived products remains robust, and analysts expect earnings momentum to rebuild as temporary headwinds ease.
So, with its shares trading close to a 52-week low, CSL's valuation looks significantly more appealing than it has in years.
Morgans sees meaningful upside from current levels. It has a buy rating and a $249.51 price target on its shares, which suggests that they could rise almost 40%.
REA Group Ltd (ASX: REA)
Finally, REA Group could be an ASX 200 blue chip share to buy now. It dominates Australia's online property advertising market, supported by powerful pricing power, strong customer relationships, and significant digital scale.
It has also expanded beyond listings into financial services, data products, and international investments, broadening its growth runway. With more interest rate cuts potentially coming in 2026, the company's premium positioning and deep integration into the property ecosystem give it substantial leverage to any improvement in listing volumes.
Bell Potter remains bullish. It has a buy rating and $244.00 price target on its shares, implying nearly 25% upside from current levels.
